Finance

Beta
Lists
RGBP:OTCMKTS
Regen BioPharma Inc
$1.95
0.00%
(0.00) 1D
Mar 31, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGBP...
High
$2.18
Low
$1.95
Mkt. cap
21.36K
Avg. vol.
15.04K
Volume
3.20K
52-wk high
$19.80
52-wk low
$1.25
EPS
-$0.64
Beta
6.38
Shares outstanding
3.37M
No. of employees
1
High
$2.18
Low
$1.95
Mkt. cap
21.36K
Avg. vol.
15.04K
Volume
3.20K
52-wk high
$19.80
52-wk low
$1.25
EPS
-$0.64
Beta
6.38
Shares outstanding
3.37M
No. of employees
1
News stories
From sources across the web
About Regen BioPharma Inc
CEO-
Employees1
Founded2012
HeadquartersLa Mesa, California, United States
SectorBiotechnology
Websiteregenbiopharmainc.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
59.06K
59.37K
59.06K
59.06K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
11.72K
210.00K
2.22K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99.82K
170.70K
400.69K
210.56K
Operating expense
99.82K
182.42K
610.69K
212.77K
Total operating expenses
99.82K
182.42K
610.69K
212.77K
Operating income
-40.76K
-123.06K
-551.62K
-153.71K
Other non operating income
-89.26K
-349.22K
-380.83K
1.18M
EBT including unusual items
-167.29K
-572.47K
-967.85K
991.93K
EBT excluding unusual items
-167.29K
-572.47K
-967.85K
991.93K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-167.29K
-572.47K
-967.85K
991.93K
Net profit margin
-283.23%
-964.30%
-1,638.62%
1,679.38%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-37.28K
-100.20K
-35.40K
-36.04K
Net interest expenses
-37.28K
-100.20K
-35.40K
-36.04K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer